XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1

Major Customers, Partnerships and Strategic Alliances (Tables)

9 Months Ended

Sep. 30, 2017

Bioverativ Inc [Member]

Research and Development Arrangement, Contract to Perform for Others [Line Items]

Revenues Recognized under Agreement

Revenues recognized under the agreement with Bioverativ for the three months and nine months ended September 30, 2017 and 2016 were as follows (in thousands):

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2017				2016				2017				2016
Revenue related to Bioverativ Collaboration:
Recognition of upfront fee		$	442			$	607			$	1,326			$	1,823
Research services			2,959				1,238				7,736				5,163
Total		$	3,401			$	1,845			$	9,062			$	6,986

Shire AG [Member]

Research and Development Arrangement, Contract to Perform for Others [Line Items]

Revenues Recognized under Agreement

Revenues recognized under the agreement with Shire for the three and nine months ended September 30, 2017 and 2016 were as follows (in thousands):

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2017				2016				2017				2016
Revenue related to Shire Collaboration:
Recognition of upfront fee		$	1,166			$	542			$	2,333			$	1,625
Research services			6				165				116				957
Total		$	1,172			$	707			$	2,449			$	2,582

Sigma-Aldrich Corporation [Member]

Research and Development Arrangement, Contract to Perform for Others [Line Items]

Revenues Recognized under Agreement

Revenues recognized under the agreement with Sigma for the three and nine months ended September 30, 2017 and 2016 were as follows (in thousands):

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2017				2016				2017				2016
Revenue related to Sigma Collaboration:
Royalty revenues		$	18			$	42			$	68			$	103
License fee revenues			—				7				267				77
Total		$	18			$	49			$	335			$	180

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of contractual arrangements that involve two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity. Additionally, the element may include all other transactions of the entity categorized collectively, if such comparison of collaborative arrangements as a component of all transactions of the entity is desired.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 808
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434

+ Details

Name:	us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_CounterpartyNameAxis=sgmo_BioverativIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_CounterpartyNameAxis=sgmo_ShireAgMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_CounterpartyNameAxis=sgmo_SigmaAldrichCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: